Liver cancer ablation with extracorporeal high-intensity focused ultrasound.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 8513829.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent animal studies have demonstrated the capacity of high-intensity focused ultrasound (HIFU) to extracorporeally ablate selective tissue targets in the liver without requiring surgical exposure of the liver or insertion of instruments into the liver. The potential value of HIFU as a noninvasive local treatment for human hepatic cancers has attracted considerable interest. This report reviews the current status of HIFU research and sets forth questions for future study.
Medical subject headings
- Liver
- Liver Neoplasms
- Ultrasonic Therapy